Black Diamond Therapeutics Inc at Cowen Health Care Conference Transcript
Welcome to the TD Cowen Health Care Conference. I'm Marc Frahm from the biotech team. Really happy to have -- next up is Black Diamond Therapeutics and the CEO, David Epstein, who's going to discuss the programs right now in lung cancer and GBM that are in the clinic as well some that are nearing the clinic. And then if we have time at the end, we will have some Q&A where Sergey, the CMO, will also join us. With that, I'll hand it over to David.
Thank you, Marc. So can you hear me? Okay. So thank you and welcome to this afternoon's presentation. Really excited to be here and talk about what we're doing at Black Diamond Therapeutics. So before getting into that, I do want to remind everybody that the presentation contains forward-looking statements, particularly with respect to our clinical programs, our discovery programs, and our use of proceeds.
This is an exciting year for Black Diamond Therapeutics. It's a catalyst-rich year. So we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |